Horizon Pharma to buy Hyperion Therapeutics By: MarketWatch March 30, 2015 at 07:28 AM EDT Horizon Pharma agrees to buy Hyperion Therapeutics for $955.7 million, or $46 a share, in cash as it looks to expand its drug portfolio. Read More >> Related Stocks: Horizon Therapeutics Macy's